Parliament considered the amendments to the Law of Georgia on Medicine and Pharmaceutical Activities by 78 votes to 2 in the third reading today.
The Bill envisages the establishment of GMP standards for imported medicines and the improvement of accessibility to high-quality products.
The change in the current law is due to the fact that the law has already entered into force on the requirement of GMP standards for locally produced medicines, and it is important that local manufacturers and importers are on equal terms.
Changes in the law should promote healthy competition and ensure a level playing field between pharmaceutical manufacturers, wholesale distributors, and pharmaceutical importers.
The draft is a legislative initiative of the government and was considered by the Parliament in an expedited manner.
